Cargando…

ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma

Long-chain acyl-CoA dehydrogenase (ACADL) is a mitochondrial enzyme that catalyzes the initial step of fatty acid oxidation, but the role of ACADL in tumor biology remains largely unknown. Here, we found that ACADL was frequently downregulated in hepatocellular carcinoma (HCC), and its low expressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xiaofang, Qin, Wenhao, Jiang, Youhai, Yang, Zhishi, Yuan, Bo, Dai, Rongyang, Shen, Hao, Chen, Yao, Fu, Jing, Wang, Hongyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096519/ https://www.ncbi.nlm.nih.gov/pubmed/32219176 http://dx.doi.org/10.1038/s41698-020-0111-4

Ejemplares similares

ACADL Functions as a Tumor Suppressor in Hepatocellular Carcinoma Metastasis by Inhibiting Matrix Metalloproteinase 14
por: Guo, Danfeng, et al.
Publicado: (2022)

ACADL Promotes the Differentiation of Goat Intramuscular Adipocytes
por: Li, An, et al.
Publicado: (2023)

Effect of ACADL on the differentiation of goat subcutaneous adipocyte
por: Li, A, et al.
Publicado: (2023)

Bulk and single-cell transcriptome profiling reveal extracellular matrix mechanical regulation of lipid metabolism reprograming through YAP/TEAD4/ACADL axis in hepatocellular carcinoma
por: Cai, Jingwei, et al.
Publicado: (2023)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway
por: Gu, Jiayi, et al.
Publicado: (2019)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma
por: LaQuaglia, Michael J., et al.
Publicado: (2016)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer
por: Sun, Min, et al.
Publicado: (2017)

The Hippo/YAP signaling pathway: the driver of cancer metastasis
por: Zhou, Tianxing, et al.
Publicado: (2023)

Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma
por: Shi, Hewen, et al.
Publicado: (2023)

The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling
por: Choi, Sunkyung, et al.
Publicado: (2022)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

SCRIB Promotes Proliferation and Metastasis by Targeting Hippo/YAP Signalling in Colorectal Cancer
por: Shen, Hengyang, et al.
Publicado: (2021)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

An emerging role for Hippo-YAP signaling in cardiovascular development
por: Zhou, Jiliang
Publicado: (2014)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
por: Wang, Shuai, et al.
Publicado: (2020)

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)

The role of Hippo‐YAP signaling in squamous cell carcinomas
por: Maehama, Tomohiko, et al.
Publicado: (2020)

Hippo-Yap Pathway Orchestrates Neural Crest Ontogenesis
por: Zhao, Xiaolei, et al.
Publicado: (2021)

Clinical potential of the Hippo-YAP pathway in bladder cancer
por: Cheng, Xin, et al.
Publicado: (2022)

New Insights into Hippo/YAP Signaling in Fibrotic Diseases
por: Mia, Masum M., et al.
Publicado: (2022)

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer
por: Koinis, Filippos, et al.
Publicado: (2022)

The KLF7/PFKL/ACADL axis modulates cardiac metabolic remodelling during cardiac hypertrophy in male mice
por: Wang, Cao, et al.
Publicado: (2023)

High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
por: Moon, Hyuk, et al.
Publicado: (2019)

YAP–VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP
por: Cai, Jing, et al.
Publicado: (2022)

Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer
por: Wang, Tianshi, et al.
Publicado: (2023)

Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma
por: Hu, Hao, et al.
Publicado: (2020)

Clinical implications of the Hippo-YAP pathway in multiple cancer contexts
por: Kim, Han-Byul, et al.
Publicado: (2018)

Hippo signaling dysfunction induces cancer cell addiction to YAP
por: Han, Han, et al.
Publicado: (2018)

The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin
por: Rognoni, Emanuel, et al.
Publicado: (2019)

The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling
por: Hillmer, Ryan E., et al.
Publicado: (2019)

The role of extracellular biophysical cues in modulating the Hippo-YAP pathway
por: Mo, Jung-Soon
Publicado: (2017)

MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer
por: Lee, Na-Hyun, et al.
Publicado: (2021)

The Hippo–YAP Signaling as Guardian in the Pool of Intestinal Stem Cells
por: Seo, Yoojin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vestbji3g9rne81ce2mu72ejuk